Global Serum Lactate Testing Market Growth (Status and Outlook) 2022-2028

Global Serum Lactate Testing Market Growth (Status and Outlook) 2022-2028

Product Code:353195

Published Date: Jan 18,2022

Pages: 112

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

As the global economy mends, the 2021 growth of Serum Lactate Testing will have significant change from previous year. According to our (LP Information) latest study, the global Serum Lactate Testing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Serum Lactate Testing market size will reach USD  million in 2028, growing at a CAGR of  % over the analysis period.

The United States Serum Lactate Testing market is expected at value of US$  million in 2021 and grow at approximately  % CAGR during review period. China constitutes a  % market for the global Serum Lactate Testing market, reaching US$  million by the year 2028. As for the Europe Serum Lactate Testing landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at  % and  % respectively for the next 5-year period.

Global main Serum Lactate Testing players cover ApexBio, EKF Diagnostics, Nova Biomedical, and Arkray, etc. In terms of revenue, the global largest two companies occupy a share nearly  % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Serum Lactate Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
    Lactate Dehydrogenase (LDH)
    LDH isoenzyme blood test
    Lactic acid test
    Lactose tolerance tests
    Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
    Hospitals
    Clinics
    Home Care
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    ApexBio
    EKF Diagnostics
    Nova Biomedical
    Arkray
    F. Hoffmann-La Roche
    Beckman Coulter
    LifeSpan BioSciences
    Aviva Systems Biology Corporation
    Accurex Biomedical
    Thermo Fisher Scientific
    PerkinElmer
    Quest Diagnostics
    Abcam
    Anamol Laboratories Private
    Randox Laboratories
    Sigma-Aldrich
    Merck KGaA